Mineral bone disorders in kidney disease patients: the ever-current topic

L Hu, A Napoletano, M Provenzano, C Garofalo… - International Journal of …, 2022 - mdpi.com
Chronic kidney disease (CKD) is a complex and multifactorial disease, and one of the most
prevalent worldwide. Chronic kidney disease–mineral bone disorders (CKD–MBD) with …

Vascular calcification and cellular signaling pathways as potential therapeutic targets

JH Kang, T Kawano, M Murata, R Toita - Life Sciences, 2024 - Elsevier
Increased vascular calcification (VC) is observed in patients with cardiovascular diseases
such as atherosclerosis, diabetes, and chronic kidney disease. VC is divided into three types …

[HTML][HTML] Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney …

JV Torregrosa, J Bover, MR Portillo, EG Parra… - Nefrología (English …, 2023 - Elsevier
As in 2011, when the Spanish Society of Nephrology (SEN) published the Spanish
adaptation to the Kidney Disease: Improving Global Outcomes (KDIGO) universal Guideline …

Recommended calcium intake in adults and children with chronic kidney disease—a European consensus statement

P Evenepoel, HS Jørgensen, J Bover… - Nephrology Dialysis …, 2024 - academic.oup.com
Mineral and bone disorders (MBD) are common in patients with chronic kidney disease
(CKD), contributing to significant morbidity and mortality. For several decades, the first-line …

An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profiles

H Ogata, A Takeshima, H Ito - Expert opinion on drug safety, 2022 - Taylor & Francis
Introduction Hyperphosphatemia is an inevitable complication for patients undergoing
dialysis, as is the resulting need for treatment with phosphate binders. Currently, various …

Thermal Air Oxidation-Mediated Synchronous Coordination and Carbonation of Lanthanum on Biochar toward Phosphorus Adsorption from Wastewater

M Hu, C Liang, H Zhou, K Guo, W Zhu… - Inorganic Chemistry, 2023 - ACS Publications
Biochar has attracted increasing attention as the sustainable and structure-tunable carrier
for lanthanum (La) species for diverse applications. Carbonated La species possesses a …

[HTML][HTML] Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

M Ketteler, P Evenepoel, RM Holden, T Isakova… - Kidney international, 2025 - Elsevier
In 2017, Kidney Disease: Improving Global Outcomes (KDIGO) published a Clinical Practice
Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic …

Bone marrow mesenchymal stem cell-derived exosomal microRNA-381-3p alleviates vascular calcification in chronic kidney disease by targeting NFAT5

Y Liu, Y Guo, S Bao, H Huang, W Liu, W Guo - Cell Death & Disease, 2022 - nature.com
Vascular calcification (VC) is a significant complication of chronic kidney disease (CKD) and
cellular apoptosis is one of the intricate mechanisms of VC. Bone marrow mesenchymal …

[HTML][HTML] Recomendaciones de la Sociedad Española de Nefrología para el manejo de las alteraciones del metabolismo óseo-mineral en los pacientes con …

JV Torregrosa, J Bover, MR Portillo, EG Parra… - nefrologia, 2022 - Elsevier
Al igual a como ocurrió en el año 2011, cuando la Sociedad Española de Nefrología (SEN)
publicó la adaptación española a las guías universales Kidney Disease Initiative Global …

Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone—Vascular paradox, a …

MJ Williams, SC White, Z Joseph, KA Hruska - Frontiers in Physiology, 2023 - frontiersin.org
The chronic kidney disease-mineral bone disorder (CKD-MBD) is a complex multi-
component syndrome occurring during kidney disease and its progression. Here, we update …